Report cover image

Global Non-Hospital-Based Point-Of-Care Diagnostic Product Market Growth (Status and Outlook) 2026-2032

Published Mar 06, 2026
Length 156 Pages
SKU # LPI20938970

Description

The global Non-Hospital-Based Point-Of-Care Diagnostic Product market size is predicted to grow from US$ 13570 million in 2025 to US$ 22700 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.

Non-hospital-based Point-of-Care (POC) diagnostic products are medical devices and tests designed for use outside of traditional hospital settings, such as in clinics, pharmacies, or even at home. These products enable immediate and convenient health assessments, allowing patients and healthcare providers to monitor conditions like glucose levels, cholesterol, infections, and other health indicators. Non-hospital-based POC diagnostics play a vital role in early diagnosis, ongoing management of chronic conditions, and improving access to healthcare in remote or underserved areas.

United States market for Non-Hospital-Based Point-Of-Care Diagnostic Product is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Non-Hospital-Based Point-Of-Care Diagnostic Product is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Non-Hospital-Based Point-Of-Care Diagnostic Product is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Non-Hospital-Based Point-Of-Care Diagnostic Product players cover Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Non-Hospital-Based Point-Of-Care Diagnostic Product Industry Forecast” looks at past sales and reviews total world Non-Hospital-Based Point-Of-Care Diagnostic Product sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Hospital-Based Point-Of-Care Diagnostic Product sales for 2026 through 2032. With Non-Hospital-Based Point-Of-Care Diagnostic Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Hospital-Based Point-Of-Care Diagnostic Product industry.

This Insight Report provides a comprehensive analysis of the global Non-Hospital-Based Point-Of-Care Diagnostic Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Hospital-Based Point-Of-Care Diagnostic Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Hospital-Based Point-Of-Care Diagnostic Product market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Hospital-Based Point-Of-Care Diagnostic Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Hospital-Based Point-Of-Care Diagnostic Product.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Hospital-Based Point-Of-Care Diagnostic Product market by product type, application, key players and key regions and countries.

Segmentation by Type:
Consumables
Devices

Segmentation by Application:
Household
Laboratory
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Bio-Rad Laboratories
Nova Biomedical
QuidelOrtho
Accriva
OraSure Technologies
Helena Laboratories
Phamatech
Chembio Diagnostics
Trinity Biotech
Wuhan Easy Diagnosis
Intec PRODUCT
Sinocare
Wondfo
Getein Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

156 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Non-Hospital-Based Point-Of-Care Diagnostic Product Market Size by Player
4 Non-Hospital-Based Point-Of-Care Diagnostic Product by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Non-Hospital-Based Point-Of-Care Diagnostic Product Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.